Today’s pharmaceutical distribution supply chain is governed largely by a patchwork of state laws and regulations that allows criminals to enter markets with the lowest safety requirements to inject counterfeit, unsafe, and potentially lethal products into the national supply chain. The state-by-state system is both onerous and ineffective, and the risk it poses to public health from counterfeiters can no longer be ignored.
In a recent opinion piece for Roll Call, I write that:
“Congress must establish a federal tracking system to protect consumers from illicit, counterfeit and possibly deadly drugs. A single, uniform national solution is needed to best protect consumers and patients across the country…”